Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

4420456374_64a3d7e6aa

Top ten stories in the pharmaceutical industry this week

August 19, 2016 Medical Communications pharmafile, top ten

The end of another week, and from huge expansions and investments to some shocking and saddening tragedies, it’s been a …
News
teva_copy

EU grants marketing authorisation for Teva’s asthma drug Cinqaero

August 19, 2016 Medical Communications, Sales and Marketing EU, Teva, approval, asthma, cinqaero, eosinophilic

The European Commission has granted marketing authorisation for Teva’s Cinqaero (reslizumab), as an odd-on therapy in adult patients with severe …
News

Bayer’s liver cancer drug not cost-effective, says NICE

August 19, 2016 Medical Communications, Sales and Marketing Bayer, CDF, NICE, Nexavar, lung cancer

NICE has deemed Bayer’s liver cancer drug Nexavar (sorafenib) as not cost-effective. The drug is currently available on the Cancer …
News
gavel

Former shareholders sue Valeant, alleging “vast fraud”

August 19, 2016 Medical Communications, Sales and Marketing Valeant, fraud, lawsuit, t rowe price

Valeant Pharmaceuticals has confirmed that it is being sued by one its former largest shareholders, T Rowe Price, who claim …
News
clinical_trial_3

Intercept’s Ocaliva meets primary endpoint in Phase III trial for rare liver disease

August 18, 2016 Medical Communications, Research and Development intercept, ocaliva

Intercept Pharmaceuticals have announced the publication of Phase III results published in the New England Journal of Medicine, where Ocaliva …
News
shutterstock_512649

Chinese investors plan $1 billion US biotech site

August 18, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

China’s state-backed developer Greenland Holdings is set to jointly invested over $1 billion in a San Francisco-based biotech industrial park …
News

Pfizer’s Xalkori price drop secures NICE recommendation

August 18, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NICE, Pfizer, Xalkori, crizotinib, lung cancer

The National Institute for Health and Care Excellence (NICE) has recommended Pfizer’s Xalkori (crizotinib) as a treatment for lung cancer, …
News

Ashfield launches Global Impact On Society Initiative

August 16, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Ashfield, part of UDG Healthcare plc (LON: UDG), a global leader in providing outsourced healthcare services to pharmaceutical, device and …
News
Press release
top_ten

Top ten stories in the pharmaceutical industry this week

August 15, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biggest stories, pharma, pharmafile, stories of the week, top 10

It’s Monday and we’re just getting back to it after a busy week in pharma. Unfortunately, it was mostly bad …
News

Ashfield publishes a guide to Patient Support Programmes: Ten steps to success

August 12, 2016 Medical Communications, Research and Development, Sales and Marketing

The priorities of Pharma and healthcare organisations are better aligned as a result of the industry’s increased efforts to put …
News
Press release
cdc1

Number of babies born with opioid dependence has tripled in US, says CDC report

August 12, 2016 Medical Communications, Research and Development CDC, addicted, babies, opioid dependence, opioids

A new report from the Centers for Disease Control and Prevention (CDC) has highlighted a sharp increase in the number …
News
allergan

Allergan set to acquire eye-care biotech ForSight VISION5

August 12, 2016 Medical Communications, Sales and Marketing Allergan, ForSight VISION5, acquisition, biotech, eye care

Allergan has announced its acquisition of privately-held, clinical-stage eye-care biotech ForSight VISION5 for a $95 million upfront payment and a …
News

Novartis admits employees gave kickbacks to doctors in South Korea

August 12, 2016 Medical Communications, Research and Development Novartis, kickbacks, south korea

Novartis has confirmed that six employees in South Korea gave kickbacks to doctors, as the current and former employees face …
News
laboratory-testing-az

Advaxis follows up Amgen deal with Phase IIa cancer trial success

August 12, 2016 Medical Communications, Research and Development Advaxis, immunotherapy. cancer. Amgen

Advaxis, a US biotech in cancer immunotherapy development, has announced that its lead immunotherapy product axalimogene filolisbac (AXAL) has hit …
News
gilead-sciences

Gilead to work with Genmab on HIV targeting technology

August 12, 2016 Medical Communications, Research and Development, Sales and Marketing Genmab, Gilead, HIV, duobody

Genmab has announced that it has entered into a collaboration deal with Gilead Sciences to use the DuoBody technology platform …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025